The invention belongs to the technical field of
drug co-delivery, and particularly relates to a nano-platform based on attenuated
bacterial outer membrane vesicles and capable of achieving co-delivery of siRNA and adriamycin and a preparation method of the nano-platform. The preparation method comprises the following steps: synthesizing an ROS
response type cationic
polymer PTP; the preparation method comprises the following steps: preparing
aptamer-DOX; preparing an ROS (
reactive oxygen species)
response type positive electric nano core PTP / 47aD; extracting and purifying the [
delta] msbB OMVs; synthesizing a target functional unit DSPE-PEG2k-Angiopep-2 (Distearoyl
Phosphate Polyethylene Glycol 2k-Angiopep-2); finally, the ROS
response type co-delivery nano platform AO (at) PTP / 47aD is prepared and obtained. The co-delivery nano-platform prepared by the invention is relatively small in particle size, uniform in morphology and relatively high in
biological safety, and has no obvious damage to various tissues and visceral organs. The
glioblastoma immunopotentiator can be used as a general platform for
gene delivery, can also be used as an immune activator, is suitable for intravenous injection administration, and can comprehensively overcome
immune resistance of
glioblastoma.